Response to: 'Remission or low disease activity as a target in systemic lupus erythematosus' by Ugarte-Gil et al

被引：1
|
作者：
Zen, Margherita [1 ]
Doria, Andrea [1 ]
机构：
[1] Univ Padua, Dept Med, Rheumatol Unit, I-35128 Padua, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷 / 01期
关键词：
PROLONGED REMISSION; CAUCASIAN PATIENTS; ACTIVITY STATE; DAMAGE; PREVALENCE; COHORT; SLE;
D O I：
10.1136/annrheumdis-2017-212911
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Clinical Remission and Low Disease Activity Outcomes Over 10 Years in Systemic Lupus Erythematosus
    Tselios, Konstantinos
    Gladman, Dafna D.
    Touma, Zahi
    Su, Jiandong
    Anderson, Nicole
    Urowitz, Murray B.
    ARTHRITIS CARE & RESEARCH, 2019, 71 (06) : 822 - 828
  • [2] Prolonged clinical remission and low disease activity statuses are associated with better quality of life in systemic lupus erythematosus
    Poomsalood, N.
    Narongroeknawin, P.
    Chaiamnuay, S.
    Asavatanabodee, P.
    Pakchotanon, R.
    LUPUS, 2019, 28 (10) : 1189 - 1196
  • [3] Glucocorticoid withdrawal in systemic lupus erythematosus: are remission and low disease activity reliable starting points for stopping treatment? A real-life experience
    Tani, Chiara
    Elefante, Elena
    Signorini, Viola
    Zucchi, Dina
    Lorenzoni, Valentina
    Carli, Linda
    Stagnaro, Chiara
    Ferro, Francesco
    Mosca, Marta
    RMD OPEN, 2019, 5 (02):
  • [4] Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort
    Francisco Ugarte-Gil, Manuel
    Hanly, John
    Urowitz, Murray
    Gordon, Caroline
    Bae, Sang-Cheol
    Romero-Diaz, Juanita
    Sanchez-Guerrero, Jorge
    Bernatsky, Sasha
    Clarke, Ann Elaine
    Wallace, Daniel J.
    Isenberg, David Alan
    Rahman, Anisur
    Merrill, Joan T.
    Fortin, Paul R.
    Gladman, Dafna D.
    Bruce, Ian N.
    Petri, Michelle
    Ginzler, Ellen M.
    Dooley, Mary Anne
    Ramsey-Goldman, Rosalind
    Manzi, Susan
    Jonsen, Andreas
    van Vollenhoven, Ronald F.
    Aranow, Cynthia
    Mackay, Meggan
    Ruiz-Irastorza, Guillermo
    Lim, Sam
    Inanc, Murat
    Kalunian, Ken
    Jacobsen, Soren
    Peschken, Christine
    Kamen, Diane L.
    Askanase, Anca
    Pons-Estel, Bernardo A.
    Alarcon, Graciela S.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (11) : 1541 - 1548
  • [5] Caveats and pitfalls in defining low disease activity in systemic lupus erythematosus
    Samoes, Beatriz
    Zen, Margherita
    Abelha-Aleixo, Joana
    Gatto, Mariele
    Doria, Andrea
    AUTOIMMUNITY REVIEWS, 2022, 21 (10)
  • [6] Achieving remission or low disease activity is associated with better outcomes in patients with systemic lupus erythematosus: a systematic literature review
    Ugarte-Gil, Manuel Francisco
    Mendoza-Pinto, Claudia
    Reategui-Sokolova, Cristina
    Pons-Estel, Guillermo J.
    van Vollenhoven, Ronald F.
    Bertsias, George
    Alarcon, Graciela S.
    Pons-Estel, Bernardo A.
    LUPUS SCIENCE & MEDICINE, 2021, 8 (01):
  • [7] How can we define low disease activity in systemic lupus erythematosus?
    Tselios, Konstantinos
    Gladman, Dafna D.
    Urowitz, Murray B.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2019, 48 (06) : 1035 - 1040
  • [8] Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort
    Ugarte-Gil, Manuel F.
    Wojdyla, Daniel
    Pons-Estel, Guillermo J.
    Quintana, Rosana
    Gomez-Puerta, Jose A.
    Catoggio, Luis J.
    Alvarellos, Alejandro
    Saurit, Veronica
    Borba, Eduardo
    Sato, Emilia
    Costallat, Lilian
    Da Silva, Nilzio A.
    Iglesias-Gamarra, Antonio
    Neira, Oscar
    Reyes-Llerena, Gil
    Cardiel, Mario H.
    Amigo, Mary Carmen
    Acevedo-Vasquez, Eduardo
    Esteva-Spinetti, Maria H.
    Alarcon, Graciela S.
    Pons-Estel, Bernardo A.
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (10) : 1299 - 1308
  • [9] Impact of remission and low disease activity on health-related quality of life in patients with systemic lupus erythematosus
    Emamikia, Sharzad
    Oon, Shereen
    Gomez, Alvaro
    Lindblom, Julius
    Borg, Alexander
    Enman, Yvonne
    Morand, Eric
    Grannas, David
    van Vollenhoven, Ronald F.
    Nikpour, Mandana
    Parodis, Ioannis
    RHEUMATOLOGY, 2022, 61 (12) : 4752 - 4762
  • [10] Defining Low Disease Activity in Systemic Lupus Erythematosus
    Polachek, Ari
    Gladman, Dafna D.
    Su, Jiandong
    Urowitz, Murray B.
    ARTHRITIS CARE & RESEARCH, 2017, 69 (07) : 997 - 1003
12345